Laboratorio de Diseño Molecular, Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Ciudad Universitaria, C.P. 58030, Morelia, Michoacán, Mexico.
Laboratorio de Diferenciación Celular, Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Ed. B-1, Ciudad Universitaria, Morelia, Michoacán 58030, Mexico.
Org Biomol Chem. 2024 Sep 11;22(35):7240-7244. doi: 10.1039/d4ob00995a.
A synthetic strategy for obtaining a new series of 1,5-disubstituted tetrazole-benzofuran hybrid systems a one-pot five-component reaction is described. This process involves a Ugi-azide multicomponent reaction coupled to an intramolecular cyclization catalyzed by Pd/Cu, resulting in low to moderate yields from 21 to 67%. This protocol allowed the synthesis of highly substituted benzofurans at the 2-position through an operationally simple process under mild reaction conditions and with high bond forming efficiency due to the formation of six new bonds (two C-C, two C-N, one N-N, and one C-O). Besides, to evaluate the antifungal activity of 1,5-disubstituted tetrazole-benzofurans 9a-n, studies against were performed, finding that compound 9b exhibits bioactivity comparable to the commercial antifungal drug Amphotericin B. These results suggest potential for use in controlling mucormycosis infections in animal models, highlighting the importance of these findings given the limited antifungal drug options and high mortality rates associated with this infection.
一种合成 1,5-取代的四唑-苯并呋喃杂合体系的新方法 一锅法五组分反应被描述。该过程涉及 Ugi-叠氮化物多组分反应与 Pd/Cu 催化的分子内环化偶联,产率从 21%至 67%不等。该方案通过温和反应条件下操作简单的过程,通过形成六个新键(两个 C-C、两个 C-N、一个 N-N 和一个 C-O)实现了高效的键形成,从而在 2 位合成了高取代的苯并呋喃。此外,为了评估 1,5-取代的四唑-苯并呋喃 9a-n 的抗真菌活性,对 进行了研究,发现化合物 9b 表现出与商业抗真菌药物两性霉素 B 相当的生物活性。这些结果表明,在动物模型中控制毛霉菌感染具有潜在用途,鉴于这种感染的抗真菌药物选择有限和死亡率高,这些发现非常重要。